You are here: Industry Insights > antibiotic

News List

Oral Antibiotic Use Linked to Risk for Colorectal Cancer drugs
August 22, 2019
Oral antibiotic use is associated with an increased risk for colon cancer and a reduced risk for rectal cancer, according to a study published online in Gut.
FDA Approves Antibiotic for Community-Acquired Pneumonia contractpharma
August 22, 2019
Patients treated with Xenleta had similar rates of clinical success as those treated with moxifloxacin with or without linezolid.
Mechanical, Oral Antibiotic Bowel Prep Yields No Benefit for Colectomy drugs
August 20, 2019
Mechanical and oral antibiotic bowel preparation (MOABP) does not reduce surgical site infections (SSIs) or the overall morbidity of colon surgery versus no bowel preparation (NBP)...
New Antibiotic Xenleta Approved for Community-Acquired Bacterial Pneumonia drugs
August 20, 2019
Xenleta (lefamulin) has been approved to treat adults with community-acquired bacterial pneumonia, the U.S. Food and Drug Administration announced .
Ancient natural history of antibiotic production and resistance revealed worldpharmanews
August 13, 2019
A study from McMaster University has unearthed new details about the evolutionary history of both antibiotic production and resistance and dates their co-emergence as far back as 350 to 500 million years.
Poor Pneumonia Outcomes Tied to Overuse of Broad-Spectrum Antibiotics drugs
August 07, 2019
Overuse of broad-spectrum antibiotics is associated with increased mortality and other poor outcomes in adults admitted for community-onset pneumonia...
Nosopharm, Evotec to Develop Novel Antibiotics contractpharma
July 25, 2019
Nosopharm’s lead candidate, NOSO-502, could be first antibiotic class against Enterobacteriaceae infections to enter clinics in forty years.
Nonprescription Antibiotic Use Seems Prevalent in the United States drugs
July 23, 2019
Nonprescription antibiotic use appears to be prevalent in the United States, according to a review published online in the Annals of Internal Medicine.
Current Antibiotic Stewardship Program Practices Characterized drugs
July 22, 2019
Current infection prevention and antibiotic stewardship program practices continue to include a main focus on surveillance for multidrug-resistant organisms...
Partnership with Evotec to Advance Nosopharm’s Lead Candidate contractpharma
July 17, 2019
NOSO-502 could be first novel antibiotic class against Enterobacteriaceae infections to enter clinics in forty years.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page